Answer
Breastfeeding is not recommended throughout treatment with Daurismo (glasdegib maleate) and for at least one week after the last dose because of potential serious adverse reactions in breastfed children.
Sources for this answer
- Daurismo 100mg Film Coated TabletsPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked